Identification of treatment‐induced vulnerabilities in pancreatic cancer patients using functional model systemsKatja Peschke(TUM Klinikum), Maximilian Reichert(German Cancer Research Center)EMBO Molecular MedicineFebruary 4, 202210.15252/emmm.202114876Cited by 39SaveCiteExport RISWatch citationsRelated PapersHeterogeneity-driven phenotypic plasticity and treatment response in branched-organoid models of pancreatic ductal adenocarcinoma|Nature Biomedical Engineering|2024|32Label-free single-cell phenotyping to determine tumor cell heterogeneity in pancreatic cancer in real time|JCI Insight|2025|3